Preview

Medical and Biological Problems of Life Activity

Advanced search

Epidemiological aspects and results of cytological screening for cervical cancer

Abstract

The article presents information on the incidence of cervical cancer in the Gomel region for the period from 2012 to 2019. In the structure of the incidence of women in the Gomel region, malignant tumors of the cervix in 2019 occupied the 10th ranking place and amounted to 2,65%. An increase in the incidence of cervical cancer among rural women from 14,520/0000 in 2014 was revealed to 33,530/0000 in 2019. When studying the age-specific incidence rates of cervical cancer, it was found that the maximum incidence rates were observed in the group of 35-39 years old - 30,42±3,30/0000. As a result of cytological studies using the liquid cytology method, it was found that in 95,9% of cases, pathological changes in the cervix were not detected. Cervical intraepithelial neoplasias of varying degrees (ASC-US, LSIL, HSIL) were found in 459 women, which accounted for 4,1%. The share of HSIL (44,5%) was detected in the age group of 25-39 years, which indicates a high incidence of precancerous diseases of the cervix in young women.

About the Authors

O. P. Lohinava
ГУ «РНПЦ радиационной медицины и экологии человека»
Russian Federation


N. I. Shevchenko
ГУ «РНПЦ радиационной медицины и экологии человека»
Russian Federation


I. V. Veyalkin
ГУ «РНПЦ радиационной медицины и экологии человека»
Russian Federation


O. A. Davydava
ГУ «РНПЦ радиационной медицины и экологии человека»
Russian Federation


References

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries / H. Sung [et al.] // CA Cancer J Clin. - 2021 - Vol. 71(3). - P. 209-249. doi: 10.3322/caac.21660.

2. Global cancer observatory: cancer today Lyon /j. Ferlay [et al.] // France: international agency for research on cancer. - 2018. - Vol. 3(20). - Available from: https://gco.iarc.fr/today.

3. Папилломавирусная инфекция урогенитального тракта: эпидемиологические аспекты (обзор) / О.С. Абрамовских [и др.] // Гинекология. - 2016. - Т. 18. - № 2. - С. 34-39.

4. Толмачев, Д.А. Профилактика рака шейки матки. Последствия пандемии COVID-19 / Д.А. Толмачев, Д.О. Сунцова, И.И. Ягудин // Modern Science. - 2022. - № 6-2. - С. 63-64.

5. Рак в Беларуси: цифры и факты. Анализ данных Белорусского канцер-регистра за 2010-2019 гг. / [А.Е. Океанов и др.; под ред. С.Л. Полякова]. - Минск: РНПЦ ОМР им. Н.Н. Александрова, 2020. - 298 с.

6. Эпидемиологические аспекты генитальной папилломавирусной инфекции и рака шейки матки в республике Беларусь и Гомельской области (1995-2014 гг.) / В.Н. Беляковский [и др.] // Медицинские новости. - 2016. - №7 (262). - С. 61-66.

7. Wilailak, S, Worldwide initiatives to eliminate cervical cancer/ S. Wilailak, M. Kengsakul, S. Kehoe // Int J Gynecol Obstet. - 2021. Vol. 155 (Suppl. 1). - P. 102-106.

8. Кравец, О.А. Cкрининг рака шейки матки: реализация программы в республике Казахстан / О.А. Кравец, Р.О. Болатбекова, А.А. Курманова // Онкогинекология. - № 1. - 2020. - С. 58-66.

9. Исторические аспекты цитологического скрининга рака шейки матки / М.Г. Леонов [и др.] // Волгоградский научно-медицинский журнал. - 2012. - № 4(36). - С. 6-11.

10. Скрининг рака шейки матки. Взгляд клинициста / Ю.Г. Паяниди [и др.] // Онкогинекология. - 2013. - № 1. - С. 35-42.

11. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden /j.Wang [et al.] //PLoS Med. - 2017. - P.1-17.


Review

For citations:


Lohinava O.P., Shevchenko N.I., Veyalkin I.V., Davydava O.A. Epidemiological aspects and results of cytological screening for cervical cancer. Medical and Biological Problems of Life Activity. 2022;(2):87-92. (In Russ.)

Views: 278


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2088 (Print)